View Older Stories View More Recent Stories
-
Triple Flag Files Preliminary Prospectus for Initial Public Offering of Common Shares
-
Surgery Partners, Inc. to Present at Upcoming Investor Conferences
-
Gilead Sciences (GILD) Trodelvy Likely to Retain Market Leader Position Despite Positive AZN Data as ESMO
-
uniQure Announces First Quarter 2021 Financial Results and Highlights Recent Company Progress
-
Axsome Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
-
Axsome Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
-
UPDATE: Nikola Corp. (NKLA) PT Lowered to $11 at RBC Capital
-
UPDATE: RBC Capital Upgrades Cogent Communications (CCOI) to Outperform
-
Select Interior Concepts to Sell Its RDS Segment to Interior Logic Group for $215 Million
-
UPDATE: RBC Capital Starts TuSimple Holdings Inc. (TSP) at Outperform (correction)
-
Sagicor Financial Company Ltd. Announces Expiration and Results of Cash Tender Offer for Any and All 8.875% Senior Notes due 2022 issued by Sagicor Finance (2015) Limited
-
CanWel Building Materials First Quarter 2021 Financial Results
-
MEDIA ALERT: Equinix to Speak at Upcoming Investor Conferences
-
RBC Capital Upgrades ViacomCBS (VIAC) to Outperform
-
eHealth, Inc. to Present at RBC Capital Markets Global Healthcare Conference
-
Tabula Rasa HealthCare Reports First Quarter 2021 Results
-
Gilead Sciences to Present at Upcoming Investor Conferences
-
Homology Medicines Reports First Quarter 2021 Financial Results and Recent Highlights
-
REGENXBIO to Present at Upcoming Investor Conferences
-
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2021 with Webcast and Conference Call Today at 4:30 p.m. ET
-
Builders FirstSource (BLDR) PT Raised to $68 at RBC Capital Following Earnings
-
Alaska Student Loan Corporation Announces Commencement Of Consent Solicitation Process For Its Taxable Education Loan Backed Notes, Series 2013A
-
Ionis to present at upcoming investor conferences
-
Provention Bio Reports First Quarter 2021 Financial Results and Provides Business Update
-
Canadian dollar seen consolidating gains as drumbeat builds for Fed taper: Reuters poll
-
American Tower (AMT) Prices 9M Share Upsized Common Offering at $244.75/Sh
-
Anglo Pacific Group PLC Announces Q1 2021 Trading Update
-
American Tower Corporation Prices Upsized Public Offering of Common Stock
-
MeiraGTx Announces Participation at Upcoming Investor Conferences
-
MeiraGTx Announces Participation at Upcoming Investor Conferences
-
GoodRx to Present Virtually at Upcoming Investor Conferences
-
Whiting Petroleum Reports First Quarter 2021 Financial and Operating Results
-
Acadia Healthcare to Participate in the BofA Securities 2021 Healthcare Conference and the 2021 RBC Capital Markets Global Healthcare Conference
-
UPDATE: Bausch Health Companies (BHC) PT Lowered to $41 at RBC Capital
-
UPDATE: RBC Capital Downgrades Rayonier Advanced Materials (RYAM) to Sector Perform
-
Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference
-
Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference
-
89bio to Present at Upcoming Investor Conferences
-
Intra-Cellular Therapies to Present at Two Upcoming Investor Conferences
-
89bio to Present at Upcoming Investor Conferences
-
BioCryst to Present at Upcoming Investor Conferences
-
American Tower (AMT) Announces Proposed Public 8.5M Share Offering of Common Stock
-
American Tower Corporation Announces Proposed Public Offering of Common Stock
-
T-Mobile US (TMUS) Estimates Raised at RBC Capital After Earnings
-
UPDATE: RBC Capital Upgrades Meritor (MTOR) to Outperform
-
Athabasca Oil Corporation Announces 2021 First Quarter Results, Hangingstone Cost Reductions, Inaugural ESG Report
-
Jazz Pharmaceuticals to Participate in Three Investor Conferences in May 2021
-
BioTheryX to Present at 2021 RBC Capital Markets Global Healthcare Conference
-
Sage Therapeutics (SAGE) PT Lowered to $84 at RBC Capital Following Earnings
-
Incyte (INCY) PT Lowered to $92 at RBC Capital Following Earnings

